THE EFFECT OF LENVATINIB AND PEMBROLIZUMAB ON THYROID CANCER REFRACTORY TO IODINE 131I SIMULATED BY MATHEMATICAL MODELING

DOI10.1142/S0218339022500036zbMath1486.92078OpenAlexW4220824885WikidataQ113777093 ScholiaQ113777093MaRDI QIDQ5080062

Jairo Gomes da Silva, Paulo Fernando De Arruda Mancera, Izabel Cristina Rodrigues da Silva, Mostafa Adimy

Publication date: 31 May 2022

Published in: Journal of Biological Systems (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1142/s0218339022500036

zbMATH Keywords

Lyapunov functionasymptotic stabilitymathematical modelimmunotherapyimmune systemtargeted therapythyroid tumor

Mathematics Subject Classification ID

Medical applications (general) (92C50) Biochemistry, molecular biology (92C40)

Cites Work

• A mathematical model for chemoimmunotherapy of chronic lymphocytic leukemia
• Cancer immunotherapy, mathematical modeling and optimal control
• A Mathematical Tumor Model with Immune Resistance and Drug Therapy: An Optimal Control Approach
• A MATHEMATICAL MODEL FOR TREATMENT OF PAPILLARY THYROID CANCER USING THE ALLEE EFFECT

This page was built for publication: THE EFFECT OF LENVATINIB AND PEMBROLIZUMAB ON THYROID CANCER REFRACTORY TO IODINE 131I SIMULATED BY MATHEMATICAL MODELING